Gerald L. Ray & Associates’s Edwards Lifesciences EW Stock Holding History

Gerald L. Ray & Associates’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$372K	Hold	10,206	–	–	0.05%	253
2017 Q2	$402K	Hold	10,206	–	–	0.05%	245
2017 Q1	$320K	Hold	10,206	–	–	0.04%	259
2016 Q4	$319K	Hold	10,206	–	–	0.05%	251
2016 Q3	$410K	Hold	10,206	–	–	0.06%	221
2016 Q2	$339K	Hold	10,206	–	–	0.05%	231
2016 Q1	$300K	Sell	10,206 -600	-6%	-$16.6K	0.05%	236
2015 Q4	$284K	Hold	10,806	–	–	0.04%	236
2015 Q3	$256K	Buy	10,806 +600	+6%	+$14.5K	0.04%	252
2015 Q2	$242K	Hold	10,206	–	–	0.04%	283
2015 Q1	$242K	Hold	10,206	–	–	0.04%	273
2014 Q4	$217K	Buy	+10,206	New	+$205K	0.03%	279

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gerald L. Ray & Associates's EW Position: Q3 2017 in Review

Gerald L. Ray & Associates held its Edwards Lifesciences (EW) position steady in Q3 2017 at 10,206 shares worth $372K. The position accounts for 0.05% of the portfolio, ranked #253.

Gerald L. Ray & Associates first reported a position in EW in Q4 2014 and has held it in 12 quarters since. The position peaked at $410K in Q3 2016. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

Gerald L. Ray & Associates held 10,206 shares of Edwards Lifesciences worth $372K as of Q3 2017.
Gerald L. Ray & Associates left its Edwards Lifesciences share count unchanged in Q3 2017.
Edwards Lifesciences made up 0.05% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #253 holding.
Gerald L. Ray & Associates first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 12 quarters since.
Gerald L. Ray & Associates's Edwards Lifesciences position peaked at $410K in Q3 2016.
740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.